Login / Signup

Alitretinoin Compliance in Patients with Chronic Hand Eczema.

Jung Eun SeolJong Uk KimSeong Min HongGyeong Je ChoWoo Jung JinSo Hee ParkIn Ho ParkSo Young JungHyojin Kim
Published in: Annals of dermatology (2020)
Alitretinoin appears the preferred long-term treatment option for CHE. Although there are complaints about late efficacy, cost, and side effects, following proper explanation, these should not justify discontinuation. Physicians need to recognize the reasons for poor compliance with alitretinoin for each patient and suggest continuing alitretinoin for the successful treatment of CHE.
Keyphrases
  • primary care
  • case report
  • medical education
  • combination therapy
  • smoking cessation